| Save 25% on a pre-paid one year subscription. |
|
|
382 |
Filed: 1/26/2017, Entered: None |
Unknown Document Type |
|
REDACTED VERSION of 379 Letter by Actavis Laboratories FL Inc., Aurobindo Pharma Ltd., Mylan Pharmaceuticals Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 01/26/2017)
|
|
Request |
 |
|
|
381 |
Filed: 1/26/2017, Entered: None |
Unknown Document Type |
|
REDACTED VERSION of 378 Letter to The Honorable Gregory M. Sleet from Michael P. Kelly by AstraZeneca AB. (Kelly, Michael) (Entered: 01/26/2017)
|
|
Request |
 |
|
|
380 |
Filed: 1/20/2017, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from Richard W. Riley, Esq. regarding Response to Plaintiff's January 18, 2017 Letter - re 378 Letter. (Riley, Richard) (Entered: 01/20/2017)
|
|
Request |
 |
|
|
379 |
Filed: 1/19/2017, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from Dominick T. Gattuso regarding Response to Plaintiff's January 18, 2017 Letter - re 378 Letter. (Gattuso, Dominick) (Entered: 01/19/2017)
|
|
Request |
 |
|
|
378 |
Filed: 1/19/2017, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from Michael P. Kelly. (Attachments: # 1 Exhibit A, # 2 Certificate of Service)(Kelly, Michael) (Entered: 01/19/2017)
|
|
Request |
 |
|
|
377 |
Filed: 11/4/2016, Entered: None |
Unknown Document Type |
|
Letter to The Honorable Gregory M. Sleet from David E. Moore, Esquire regarding Defendants' Electronic Version of Post-Trial Brief (DI 374). (Moore, David) (Entered: 11/04/2016)
|
|
Request |
 |
|
|
376 |
Filed: 11/3/2016, Entered: None |
Unknown Document Type |
|
Letter to The Honorable Gregory M. Sleet from Daniel M. Silver, Esq. regarding AstraZeneca's Proposed Findings of Fact and Conclusions of Law - re 373 Proposed Findings of Fact. (Silver, Daniel) (Entered: 11/03/2016)
|
|
Request |
 |
|
|
375 |
Filed: 10/28/2016, Entered: None |
Unknown Document Type |
|
JOINDER In Defendants Proposed Findings Of Fact And Conclusions Of Law by Wockhardt Bio AG, Wockhardt USA LLC, joining in 374 Proposed Findings of Fact. (Riley, Richard) Modified on 10/31/2016 (mdb). (Entered: 10/28/2016)
|
|
Request |
 |
|
|
374 |
Filed: 10/28/2016, Entered: None |
Unknown Document Type |
|
Proposed Findings of Fact by Actavis Laboratories FL Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Mylan Pharmaceuticals Inc., Watson Laboratories Inc.. (Moore, David) (Entered: 10/28/2016)
|
|
Request |
 |
|
|
373 |
Filed: 10/28/2016, Entered: None |
Unknown Document Type |
|
Proposed Findings of Fact by AstraZeneca AB. (Attachments: # 1 Exhibit A)(Silver, Daniel) (Entered: 10/28/2016)
|
|
Request |
 |
|
|
372 |
Filed: 10/26/2016, Entered: None |
Unknown Document Type |
|
Letter to The Honorable Gregory M. Sleet from Daniel M. Silver, Esq. regarding Admitted Trial Exhibit List. (Attachments: # 1 Admitted Trial Exhibit List)(Silver, Daniel) (Entered: 10/26/2016)
|
|
Request |
 |
|
|
371 |
Filed: 10/26/2016, Entered: None |
Unknown Document Type |
|
Official Transcript of Bench Trial Day 3 held on 09 21 16 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/16/2016. Redacted Transcript Deadline set for 11/28/2016. Release of Transcript Restriction set for 1/24/2017. (kjm) (Entered: 10/26/2016)
|
|
Request |
 |
|
|
370 |
Filed: 10/26/2016, Entered: None |
Unknown Document Type |
|
Official Transcript of Bench Trial Day 2 held on 09 20 16 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/16/2016. Redacted Transcript Deadline set for 11/28/2016. Release of Transcript Restriction set for 1/24/2017. (kjm) (Entered: 10/26/2016)
|
|
Request |
 |
|
|
369 |
Filed: 10/26/2016, Entered: None |
Unknown Document Type |
|
Official Transcript of Bench Trial Day 1 held on 09 19 16 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/16/2016. Redacted Transcript Deadline set for 11/28/2016. Release of Transcript Restriction set for 1/24/2017. (kjm) (Entered: 10/26/2016)
|
|
Request |
 |
|
|
368 |
Filed: 10/26/2016, Entered: None |
Unknown Document Type |
|
STIPULATION TO EXTEND TIME and [Proposed] Order Extending Time for Post-Trial Submissions to See Stip for Details - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 10/26/2016)
|
|
Request |
 |
|
|
367 |
Filed: 10/21/2016, Entered: None |
Unknown Document Type |
|
SO ORDERED - re 366 STIPULATION TO EXTEND TIME regarding Post-Trial Submissions to See Stip for Details. Setting Deadlines: (Proposed Findings of Fact and Conclusions of Law due 10/26/2016). Signed by Judge Gregory M. Sleet on 10/21/2016. (mdb) (Entered: 10/21/2016)
|
|
Request |
 |
|
|
366 |
Filed: 10/20/2016, Entered: None |
Unknown Document Type |
|
STIPULATION TO EXTEND TIME regarding Post-Trial Submissions to See Stip for Details - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 10/20/2016)
|
|
Request |
 |
|
|
365 |
Filed: 9/22/2016, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding trial. (Phillips, John) (Entered: 09/22/2016)
|
|
Request |
 |
|
|
364 |
Filed: 9/21/2016, Entered: None |
Unknown Document Type |
|
REDACTED VERSION of 357 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 09/21/2016)
|
|
Request |
 |
|
|
363 |
Filed: 9/21/2016, Entered: None |
Unknown Document Type |
|
MOTION for Pro Hac Vice Appearance of Attorney Michael Liu Su - filed by AstraZeneca AB. (Attachments: # 1 Exhibit Certification By Counsel To Be Admitted Pro Hac Vice)(Smyth, Benjamin) (Entered: 09/21/2016)
|
|
Request |
 |
|
|
362 |
Filed: 9/19/2016, Entered: None |
Unknown Document Type |
|
NOTICE of Appearance by Aaron M. Nelson on behalf of Actavis Laboratories FL Inc., Watson Laboratories Inc. (Nelson, Aaron) (Entered: 09/20/2016)
|
|
Request |
 |
|
|
361 |
Filed: 9/16/2016, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from Richard W. Riley, Esquire regarding trial. (Riley, Richard) (Entered: 09/16/2016)
|
|
Request |
 |
|
|
360 |
Filed: 9/16/2016, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from John C. Phillips, Jr. regarding trial. (Phillips, John) (Entered: 09/16/2016)
|
|
Request |
 |
|
|
359 |
Filed: 9/15/2016, Entered: None |
Unknown Document Type |
|
ORDER - denying 351 Motion to Dismiss for Lack of Subject Jurisdiction. Signed by Judge Gregory M. Sleet on 9/15/2016. (mdb) (Entered: 09/15/2016)
|
|
Request |
 |
|
|
358 |
Filed: 9/14/2016, Entered: None |
Unknown Document Type |
|
[SEALED] SO ORDERED - re 357 Stipulation filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 9/14/2016. This order has been emailed to local counsel. (mdb) (Entered: 09/14/2016)
|
|
Request |
 |
|
|
357 |
Filed: 9/14/2016, Entered: None |
Unknown Document Type |
|
[SEALED] STIPULATION and [Proposed] Order by AstraZeneca AB. (Silver, Daniel) (Entered: 09/14/2016)
|
|
Request |
 |
|
|
356 |
Filed: 9/13/2016, Entered: None |
Unknown Document Type |
|
REDACTED VERSION of 355 Letter, by AstraZeneca AB. (Silver, Daniel) (Entered: 09/13/2016)
|
|
Request |
 |
|
|
355 |
Filed: 9/13/2016, Entered: None |
Unknown Document Type |
|
[SEALED] Letter to The Honorable Gregory M. Sleet from Daniel M. Silver, Esq. regarding AstraZeneca AB's Answering Letter Brief to The Honorable Gregory M. Sleet Opposing Wockhardt's Motion to Dismiss. (Attachments: # 1 Certificate of Service)(Silver, Daniel) (Entered: 09/13/2016)
|
|
Request |
 |
|
|
354 |
Filed: 9/12/2016, Entered: None |
Unknown Document Type |
|
Official Transcript of PTC by Phone held on 09 07 16 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/3/2016. Redacted Transcript Deadline set for 10/13/2016. Release of Transcript Restriction set for 12/12/2016. (kjm) (Entered: 09/12/2016)
|
|
Request |
 |
|
|
353 |
Filed: 9/12/2016, Entered: None |
Unknown Document Type |
|
SO ORDERED - re 350 Stipulation And Order Setting Letter Briefing Schedule filed by Wockhardt USA LLC, Wockhardt Bio AG. Signed by Judge Gregory M. Sleet on 9/12/2016. (mdb) (Entered: 09/12/2016)
|
|
|
 |
|
|
352 |
Filed: 9/9/2016, Entered: None |
Unknown Document Type |
|
Letter to The Honorable Gregory M. Sleet from Richard W. Riley regarding Opening Brief in support of Motion to Dismiss for lack of subject matter jurisdiction. (Attachments: # 1 Exhibit A)(Riley, Richard) (Entered: 09/09/2016)
|
|
Request |
 |
|
|
351 |
Filed: 9/9/2016, Entered: None |
Unknown Document Type |
|
MOTION to Dismiss for Lack of Jurisdiction Over the Subject Matter - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Attachments: # 1 Text of Proposed Order)(Riley, Richard) (Entered: 09/09/2016)
|
|
Request |
 |
|
|
350 |
Filed: 9/9/2016, Entered: None |
Unknown Document Type |
|
Joint STIPULATION And Order Setting Letter Briefing Schedule by Wockhardt Bio AG, Wockhardt USA LLC. (Riley, Richard) (Entered: 09/09/2016)
|
|
Request |
 |
|
|
349 |
Filed: 9/9/2016, Entered: None |
Unknown Document Type |
|
MOTION for Pro Hac Vice Appearance of Attorney Kassandra M. Officer - filed by AstraZeneca AB. (Attachments: # 1 Certification for Kassandra M. Officer)(Silver, Daniel) (Entered: 09/09/2016)
|
|
Request |
 |
|
|
348 |
Filed: 9/6/2016, Entered: None |
Unknown Document Type |
|
Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceutical Industries, Ltd. for Actavis Laboratories FL Inc., Watson Laboratories Inc. filed by Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 09/06/2016)
|
|
Request |
 |
|
|
347 |
Filed: 9/2/2016, Entered: None |
Unknown Document Type |
|
Letter to The Honorable Gregory M. Sleet from Richard W. Riley, Esq. regarding Wockhardt's conversion to Paragraph III patent certification. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Riley, Richard) (Entered: 09/02/2016)
|
|
Request |
 |
|
|
346 |
Filed: 8/23/2016, Entered: None |
Unknown Document Type |
|
ORDER - denying 336 Motion to Stay. Signed by Judge Gregory M. Sleet on 8/23/2016. (mdb) (Entered: 08/23/2016)
|
|
Request |
 |
|
|
345 |
Filed: 8/23/2016, Entered: None |
Unknown Document Type |
|
MOTION for Pro Hac Vice Appearance of Attorney Nellie J. Amjadi of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 08/23/2016)
|
|
Request |
 |
|
|
344 |
Filed: 8/22/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of Notice Pursuant to 35 U.S. C. § 282 (filed on behalf of all Defendants) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 08/22/2016)
|
|
Request |
 |
|
|
343 |
Filed: 8/19/2016, Entered: None |
Unknown Document Type |
|
REQUEST for Oral Argument by Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Wockhardt Bio AG, Wockhardt USA LLC re 336 MOTION to Stay [The IPR Defendants' Motion to Stay Pending Inter Partes Review]. (Phillips, John) (Entered: 08/19/2016)
|
|
Request |
 |
|
|
342 |
Filed: 8/18/2016, Entered: None |
Unknown Document Type |
|
REPLY BRIEF re 336 MOTION to Stay [The IPR Defendants' Motion to Stay Pending Inter Partes Review] filed by Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Wockhardt Bio AG, Wockhardt USA LLC. (Phillips, John) (Entered: 08/18/2016)
|
|
Request |
 |
|
|
341 |
Filed: 8/15/2016, Entered: None |
Unknown Document Type |
|
REDACTED VERSION of 338 Proposed Pretrial Order by AstraZeneca AB. (Attachments: # 1 Exhibit Pt. 1 of 4, # 2 Exhibit Pt. 2 of 4, # 3 Exhibit Pt. 3 of 4, # 4 Exhibit Pt. 4 of 4)(Silver, Daniel) (Entered: 08/15/2016)
|
|
Request |
 |
|
|
340 |
Filed: 8/8/2016, Entered: None |
Unknown Document Type |
|
ANSWERING BRIEF in Opposition re 336 MOTION to Stay [The IPR Defendants' Motion to Stay Pending Inter Partes Review] filed by AstraZeneca AB.Reply Brief due date per Local Rules is 8/18/2016. (Attachments: # 1 Exhibit A-B)(Silver, Daniel) (Entered: 08/08/2016)
|
|
Request |
 |
|
|
339 |
Filed: 8/8/2016, Entered: None |
Unknown Document Type |
|
STIPULATION TO EXTEND TIME the parties to submit a public version of the Proposed Joint Pretrial Order to Monday, August 15, 2016 (from Monday, August 8, 2016) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 08/08/2016)
|
|
Request |
 |
|
|
338 |
Filed: 8/1/2016, Entered: None |
Unknown Document Type |
|
[SEALED] Proposed Pretrial Order by AstraZeneca AB. (Attachments: # 1 Exhibit A-P)(Silver, Daniel) (Entered: 08/01/2016)
|
|
Request |
 |
|
|
337 |
Filed: 7/22/2016, Entered: None |
Unknown Document Type |
|
OPENING BRIEF in Support re 336 MOTION to Stay [The IPR Defendants' Motion to Stay Pending Inter Partes Review] filed by Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Wockhardt Bio AG, Wockhardt USA LLC.Answering Brief/Response due date per Local Rules is 8/8/2016. (Phillips, John) Modified on 7/25/2016 (mdb). (Entered: 07/22/2016)
|
|
Request |
 |
|
|
336 |
Filed: 7/22/2016, Entered: None |
Unknown Document Type |
|
MOTION to Stay [The IPR Defendants' Motion to Stay Pending Inter Partes Review] - filed by Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Wockhardt Bio AG, Wockhardt USA LLC. (Attachments: # 1 Text of Proposed Order, # 2 Exhibit A-E)(Phillips, John) Modified on 7/25/2016 (mdb). (Entered: 07/22/2016)
|
|
Request |
 |
|
|
335 |
Filed: 6/29/2016, Entered: None |
Unknown Document Type |
|
MANDATE of USCA for the Federal Circuit re 146 , 147 . (Attachments: # 1 USCA Opinion) (mdb) (Entered: 06/29/2016)
|
|
Request |
 |
|
|
334 |
Filed: 5/3/2016, Entered: None |
Unknown Document Type |
|
NOTICE of Development in Related Inter Partes Review by Mylan Pharmaceuticals Inc. (Attachments: # 1 Exhibit A)(Palapura, Bindu) (Entered: 05/03/2016)
|
|
Request |
 |
|
|
333 |
Filed: 4/29/2016, Entered: None |
Unknown Document Type |
|
NOTICE requesting Clerk to remove Gina M. Bassi as co-counsel.. (Dorsney, Kenneth) (Entered: 04/29/2016)
|
|
Request |
 |
|
|
332 |
Filed: 4/26/2016, Entered: None |
Unknown Document Type |
|
MOTION for Pro Hac Vice Appearance of Attorney Nicole A. Conlon - filed by AstraZeneca AB. (Attachments: # 1 Certification for Nicole A. Conlon)(Silver, Daniel) (Entered: 04/26/2016)
|
|
Request |
 |
|
|
331 |
Filed: 4/11/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of Reply Expert Report of James C. Powers, Ph.D. filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 04/11/2016)
|
|
Request |
 |
|
|
330 |
Filed: 4/11/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of Reply Expert Report of David P. Rotella, Ph.D. [Confidential Information-Subject to Protective Order] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 04/11/2016)
|
|
Request |
 |
|
|
329 |
Filed: 4/8/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of Reply Expert Report of Garry S. Tobin, M.D. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 04/08/2016)
|
|
Request |
 |
|
|
328 |
Filed: 4/8/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of Reply Expert Report of Ivan T. Hofmann, CPA/CFF, CLP filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 04/08/2016)
|
|
Request |
 |
|
|
327 |
Filed: 3/7/2016, Entered: None |
Unknown Document Type |
|
NOTICE OF SERVICE of (1) Rebuttal Expert Report of Ann E. Weber, Ph.D., (2) Rebuttal Expert Report of M. James Lenhard, M.D. and (3) Expert Report of Christine S. Meyer, Ph.D. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 03/07/2016)
|
|
Request |
 |
|
|
326 |
Filed: 2/2/2016, Entered: None |
|
|
NOTICE OF SERVICE of Opening Expert Report of James C. Powers, Ph.D. filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 02/02/2016)
|
|
Request |
 |
|
|
325 |
Filed: 2/1/2016, Entered: None |
|
|
NOTICE OF SERVICE of Expert Report of David P. Rotella Ph.D. on the Invalidity of U.S. Patent No. RE 44,186 filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 02/01/2016)
|
|
Request |
 |
|
|
324 |
Filed: 12/15/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiffs Second Supplemental Response to Interrogatory No. 6 of Defendants First Set of Interrogatories and (2) Plaintiffs Supplemental Responses to Defendants Second Set of Joint Interrogatories (Nos. 10 and 11) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 12/15/2015)
|
|
Request |
 |
|
|
323 |
Filed: 11/20/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney John K. Hsu - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 11/20/2015)
|
|
Request |
 |
|
|
322 |
Filed: 11/19/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Amneal Pharmaceuticals LLC's Responses and Objections to Plaintiff's Fourth Set of Interrogatories to Amneal; and (2) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's Third Set of Interrogatories to Sun filed by Amneal Pharmaceuticals LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 11/19/2015)
|
|
Request |
 |
|
|
321 |
Filed: 11/19/2015, Entered: None |
|
|
NOTICE OF SERVICE of Mylan's Objections and Responses to Plaintiff's Fourth Set of Interrogatories (No. 11) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/19/2015)
|
|
Request |
 |
|
|
320 |
Filed: 11/18/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Wockhardt's Response To Plaintiffs' Third Set Of Interrogatories (No. 9) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 11/18/2015)
|
|
Request |
 |
|
|
319 |
Filed: 11/17/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Watson Laboratories, Inc. and Actavis Laboratories FL, Inc.s Objections and Response to AstraZeneca ABs Fourth Set of Interrogatories (No. 11) filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/17/2015)
|
|
Request |
 |
|
|
318 |
Filed: 11/16/2015, Entered: None |
|
|
NOTICE OF SERVICE of Aurobindo's objections and responses to Plaintiff's Third Set of Interrogatories (No. 9) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 11/16/2015)
|
|
Request |
 |
|
|
317 |
Filed: 11/3/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) AstraZeneca ABs Objections and Responses to Defendants Notice of Rule 30(b)(6) Deposition and (2) Bristol-Myers Squibb Companys Objections and Responses to Defendants Subpoena to Testify at a Deposition in a Civil Action filed by AstraZeneca AB.(Silver, Daniel) (Entered: 11/03/2015)
|
|
Request |
 |
|
|
316 |
Filed: 10/30/2015, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Objections And Responses To Astrazeneca's Second Amended Notice Of Deposition Pursuant To Fed. R. Civ. P. 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/30/2015)
|
|
Request |
 |
|
|
315 |
Filed: 10/20/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney John D. Livingstone - filed by AstraZeneca AB. (Attachments: # 1 Certification for John D. Livingstone)(Silver, Daniel) (Entered: 10/20/2015)
|
|
Request |
 |
|
|
314 |
Filed: 10/16/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiffs' Third or Fourth Set of Interrogatories to Defendants filed by AstraZeneca AB.(Silver, Daniel) (Entered: 10/16/2015)
|
|
Request |
 |
|
|
313 |
Filed: 10/5/2015, Entered: None |
 |
|
SO ORDERED - re 310 Stipulation and Proposed Order regarding Reissue Patent No. RE44 Between AstraZeneca AB and Mylan Pharmaceuticals Inc. Signed by Judge Gregory M. Sleet on 10/5/2015. (mdb) (Entered: 10/05/2015)
|
|
Request |
 |
|
|
312 |
Filed: 10/5/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's Supplemental Response to Interrogatory No. 6 of Defendants' First Set of Interrogatories filed by AstraZeneca AB.(Silver, Daniel) (Entered: 10/05/2015)
|
|
Request |
 |
|
|
311 |
Filed: 10/2/2015, Entered: None |
|
|
NOTICE to Take Deposition of Mylan Pharmaceuticals Inc. on (on a date and time to be determined) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 10/02/2015)
|
|
Request |
 |
|
|
310 |
Filed: 9/30/2015, Entered: None |
|
|
STIPULATION and Proposed Order regarding Reissue Patent No. RE44 Between AstraZeneca AB and Mylan Pharmaceuticals Inc. by AstraZeneca AB. (Silver, Daniel) Modified on 9/30/2015 (mdb). (Entered: 09/30/2015)
|
|
Request |
 |
|
|
309 |
Filed: 9/29/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Aurobindo's Second Supplemental Responses to Plaintiff's First Set of Requests for Production (Nos. 1-13); (2) Aurobindo's Second Supplemental Responses to Plaintiff's Second Set of Requests for Production (No. 14); and (3) Aurobindo's Second Supplemental Responses to Plaintiff's Third Set of Requests for Production (Nos. 15-46) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Herrmann, Richard) (Entered: 09/29/2015)
|
|
Request |
 |
|
|
308 |
Filed: 9/23/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.'s Objections and Responses to Astrazeneca's Amended Notice of Rule 30(b)(6) Deposition of Sun filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 09/23/2015)
|
|
Request |
 |
|
|
307 |
Filed: 9/21/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Actavis Laboratories FL, Inc.s Objections and Responses to Astrazenecas Amended Notice of Rule 30(b)(6) Deposition of Defendant Actavis Laboratories FL, Inc., and Defendant Watson Laboratories, Inc.s Objections and Responses to Astrazenecas Amended Notice of Rule 30(b)(6) Deposition of Defendant Watson Laboratories, Inc. filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 09/21/2015)
|
|
Request |
 |
|
|
306 |
Filed: 9/18/2015, Entered: None |
|
|
NOTICE OF SERVICE of Aurobindo's Objections to Amended Notice of Rule 30(b)(6) Deposition filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Matterer, Mary) (Entered: 09/18/2015)
|
|
Request |
 |
|
|
305 |
Filed: 9/17/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Amneal Pharmaceuticals LLC's Objections and Responses to Astrazeneca's Amended Notice of Rule 30(b)(6) Deposition of Amneal filed by Amneal Pharmaceuticals LLC.(Haney, Megan) (Entered: 09/17/2015)
|
|
Request |
 |
|
|
304 |
Filed: 9/16/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Wockhardt's Objections And Responses To Plaintiffs' Amended Notice Of Deposition Of Wockhardt Pursuant To FRCP 30(b)(6) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 09/16/2015)
|
|
Request |
 |
|
|
303 |
Filed: 9/14/2015, Entered: None |
|
|
STIPULATION TO EXTEND TIME The deadline for the parties to complete fact discovery and fact depositions prior to exchanging expert reports to See order for details - filed by AstraZeneca AB. (Brown, Daniel) (Entered: 09/14/2015)
|
|
Request |
 |
|
|
302 |
Filed: 9/10/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Mark H. Remus - filed by Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 09/10/2015)
|
|
Request |
 |
|
|
301 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 228 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Mylan. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
300 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 231 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Wockhardt. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
299 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 227 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Aurobindo. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
298 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 230 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Watson. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
297 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 226 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Amneal. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
296 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 225 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Actavis. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
295 |
Filed: 9/3/2015, Entered: None |
|
|
AMENDED DOCUMENT by AstraZeneca AB. Amendment to 229 Notice to Take Deposition AstraZeneca's Amended Notice of Rule 30(B)(6) Deposition of Defendant Sun. (Silver, Daniel) (Entered: 09/03/2015)
|
|
Request |
 |
|
|
294 |
Filed: 9/1/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Eric E. Grondahl - filed by AstraZeneca AB. (Attachments: # 1 Certification for Eric E. Grondahl)(Silver, Daniel) (Entered: 09/01/2015)
|
|
Request |
 |
|
|
293 |
Filed: 8/28/2015, Entered: None |
|
|
NOTICE to Take Deposition of Rule 30(b)(6) Deposition of AstraZeneca AB filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 08/28/2015)
|
|
Request |
 |
|
|
292 |
Filed: 8/26/2015, Entered: None |
|
|
Amended NOTICE of Deposition of Candis Edwards by AstraZeneca AB re 276 Notice to Take Deposition (Silver, Daniel) (Entered: 08/26/2015)
|
|
Request |
 |
|
|
291 |
Filed: 8/25/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney George Chih-Lun Yu - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
290 |
Filed: 8/25/2015, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiff's First Set of Requests for Admission to Mylan (Nos. 1-10) [CONFIDENTIAL]; and Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiff's Third Set of Interrogatories to Mylan (Nos. 9-10) [CONFIDENTIAL] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
289 |
Filed: 8/24/2015, Entered: None |
 |
|
SO ORDERED - re 224 Stipulation Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Actavis Laboratories Inc. filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 8/24/2015. (mdb) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
288 |
Filed: 8/24/2015, Entered: None |
 |
|
SO ORDERED - re 223 Stipulation Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Watson filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 8/24/2015. (mdb) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
287 |
Filed: 8/24/2015, Entered: None |
 |
|
SO ORDERED - re 222 Stipulation Regarding Patent No. RE44,186 between AstraZeneca AB and Amneal filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 8/24/2015. (mdb) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
286 |
Filed: 8/24/2015, Entered: None |
 |
|
SO ORDERED - re 221 Stipulation Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Sun filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 8/24/2015. (mdb) (Entered: 08/25/2015)
|
|
Request |
 |
|
|
285 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Virendra Agarwal on October 1, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
284 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Vivek Dhar on October 3, 2015 at 9:00 a.m., filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
283 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Sanjay Jain on October 3, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
282 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Priyanka Pawar on October 1, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
281 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Pranav Mehta on October 2, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
280 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Narasimhan Mani on October 2, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
279 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Manjunath Mendon on September 30, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
278 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Jigar Bhatt on September 29, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
277 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Jayesh Dahbi on September 29, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
276 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Candis Edwards on September 31, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
275 |
Filed: 8/24/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Katherine D. Hasper of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
274 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Sushil Gangwal on September 22, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
273 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Ravindra Mankar on September 18, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
272 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Soumen Pattanayek on October 5, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
271 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Napoleon Clark on October 6, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
270 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Milind Narvekar on September 30, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
269 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Ratnesh Shrivastava on September 21, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
268 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Michael Udan on October 2, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
267 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Joyce A. Delgaudio on October 7, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
266 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Janet Vaughn on October 5, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
265 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Rajeev Rihani on September 21, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
264 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Craig Jones on October 1, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
263 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Atul Kaushik on October 2, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
262 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Arunprasath Kaliaperumal on October 1, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
261 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Rajamannar Thennati on September 24, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
260 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Amit Antarkar on September 30, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
259 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Priya Gaonkar on September 23, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
258 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Manasi Padhye on September 18, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
257 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Daxesh Patel on September 17, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
256 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Bharati Nadkarni on September 22, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
255 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Anil Gite on September 23, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
254 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Vijay Pawar on September 24, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
253 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Abhay Muthal on September 17, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
252 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Venkat Naidu on September 23, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
251 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Varada Bapat on September 24, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
250 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Srinivas Rao on September 28, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
249 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Nayeem Syed on September 28, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
248 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Mandar Kodgule on September 29, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
247 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Kehsav Deo on Setpember 23, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
246 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Krishnan Venkatesan on September 25, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
245 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Balasaheb Wagh on September 29, 2015 at 9:00 a.m. filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
244 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of ANANG G. KAMAT filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
243 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of V. SUMATHI RAO filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
242 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of V. K. HANDA filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
241 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of V. NAGA PRASAD filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
240 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Joseph Sobecki on September 15, 2015 at 9:00 am filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
239 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Abhijit Deshmukh on September 14, 2015 filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
238 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of SARAVANAN KANNUSAMY filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
237 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Nitin Bhattad on September 16, 2015 filed by AstraZeneca AB.(Kelly, Michael) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
236 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of ROOPAK SAWHNEY filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
235 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of PRINCE KUMAR DEVDAS filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
234 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of K. K. C. DASARATHI filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
233 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Jayant Karajgi filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
232 |
Filed: 8/24/2015, Entered: None |
|
|
NOTICE to Take Deposition of Hemant Kumar Sharma filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/24/2015)
|
|
Request |
 |
|
|
231 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANTS WOCKHARDT BIO AG AND WOCKHARDT USA LLC filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
230 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANT WATSON LABORATORIES, INC. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
229 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANTS SUN PHARMA GLOBAL FZE AND SUN PHARMACEUTICAL INDUSTRIES LTD. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
228 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANT MYLAN PHARMACEUTICALS INC. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
227 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANTS AUROBINDO PHARMA LTD. AND AUROBINDO PHARMA U.S.A., INC. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
226 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of RULE 30(B)(6) DEPOSITION OF DEFENDANT AMNEAL PHARMACEUTICALS LLC filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
225 |
Filed: 8/21/2015, Entered: None |
|
|
NOTICE to Take Deposition of 30(b)(6) Deposition of Defendant Actavis Laboratories FL, Inc. filed by AstraZeneca AB.(Silver, Daniel) (Entered: 08/21/2015)
|
|
Request |
 |
|
|
224 |
Filed: 8/20/2015, Entered: None |
|
|
Joint STIPULATION and [Proposed] Order Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Actavis by AstraZeneca AB. (Silver, Daniel) (Entered: 08/20/2015)
|
|
Request |
 |
|
|
223 |
Filed: 8/20/2015, Entered: None |
|
|
Joint STIPULATION and [Proposed] Order Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Watson by AstraZeneca AB. (Silver, Daniel) (Entered: 08/20/2015)
|
|
Request |
 |
|
|
222 |
Filed: 8/19/2015, Entered: None |
|
|
Joint STIPULATION and [Proposed] Order Regarding Patent No. RE44,186 between AstraZeneca AB and Amneal by AstraZeneca AB. (Silver, Daniel) (Entered: 08/19/2015)
|
|
Request |
 |
|
|
221 |
Filed: 8/19/2015, Entered: None |
|
|
Joint STIPULATION and [Proposed] Order Regarding Reissue Patent No. RE44,186 between AstraZeneca AB and Sun by AstraZeneca AB. (Silver, Daniel) (Entered: 08/19/2015)
|
|
Request |
 |
|
|
220 |
Filed: 8/13/2015, Entered: None |
 |
|
Letter to The Honorable Judge Gregory M. Sleet from Daniel M. Silver, Esq. regarding Markman Hearing currently scheduled for September 25, 2015. (Silver, Daniel) (Entered: 08/13/2015)
|
|
Request |
 |
|
|
219 |
Filed: 8/11/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Joshua James - filed by Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 08/11/2015)
|
|
Request |
 |
|
|
218 |
Filed: 8/11/2015, Entered: None |
|
|
NOTICE requesting Clerk to remove Yun Wei as co-counsel. Reason for request: no longer associated with this case. (Gattuso, Dominick) (Entered: 08/11/2015)
|
|
Request |
 |
|
|
217 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Richard B. Sulsky on August 31, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
216 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Peter Ohman on September 11, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
215 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Pamela Smith on October 8, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
214 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Mike Hartman on October 5, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
213 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Lawrence G. Hamann on August 27, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
212 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Jeffrey A. Robl on September 2, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
211 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Gianmari Minervini on September 17, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
210 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of David R. Magnin on August 24, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
209 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of David A. Betebenner on September 8, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
208 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of David J. Augeri on August 20, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
207 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Chris Cann on September 21, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
206 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Cheryle Fassak on September 24, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
205 |
Filed: 8/10/2015, Entered: None |
|
|
NOTICE to Take Deposition of Boaz Hirschberg on September 14, 2015 filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 08/10/2015)
|
|
Request |
 |
|
|
204 |
Filed: 7/23/2015, Entered: None |
|
|
REDACTED VERSION of 201 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 07/23/2015)
|
|
Request |
 |
|
|
203 |
Filed: 7/21/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiff's Third Set of Interrogatories to Defendants (Nos. 9-10) and (2) Plaintiff's First Set of Requests for Admission to Defendants (Nos. 1-10) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 07/21/2015)
|
|
Request |
 |
|
|
202 |
Filed: 7/17/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 201 [Confidential] Stipulation and Proposed Order Between AstraZeneca and Aurobindo (See Stipulation For Details) filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 7/17/2015.This order has been emailed to local counsel. (mdb) (Entered: 07/20/2015)
|
|
Request |
 |
|
|
201 |
Filed: 7/16/2015, Entered: None |
|
|
[SEALED] STIPULATION [Confidential] Stipulation and Proposed Order Between AstraZeneca and Aurobindo (See Stipulation For Details) by AstraZeneca AB. (Silver, Daniel) (Entered: 07/16/2015)
|
|
Request |
 |
|
|
200 |
Filed: 7/9/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Aurobindo's supplemental responses to Plaintiff's First Set of Requests for Production (Nos. 1-13); (2) Aurobindo's supplemental responses to Plaintiff's Second Set of Requests for Production (No. 14); and (3) Aurobindo's supplemental responses to Plaintiff's Third Set of Requests for Production (Nos. 15-46) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 07/09/2015)
|
|
Request |
 |
|
|
199 |
Filed: 6/18/2015, Entered: None |
|
|
Supplemental Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Andrx Corporation for Actavis Laboratories FL Inc. filed by Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 06/18/2015)
|
|
Request |
 |
|
|
198 |
Filed: 6/15/2015, Entered: None |
|
|
REDACTED VERSION of 196 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 06/15/2015)
|
|
Request |
 |
|
|
197 |
Filed: 6/11/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 196 STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Wockhardt. Signed by Judge Gregory M. Sleet on 6/11/2015.This order has been emailed to local counsel. (mdb) (Entered: 06/12/2015)
|
|
Request |
 |
|
|
196 |
Filed: 6/8/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Wockhardt by AstraZeneca AB. (Silver, Daniel) (Entered: 06/08/2015)
|
|
Request |
 |
|
|
195 |
Filed: 6/3/2015, Entered: None |
 |
|
SO ORDERED - re 194 Stipulation Regarding Claim Construction of U.S. Patent No. RE44,186 filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 6/2/2015. (mdb) (Entered: 06/03/2015)
|
|
Request |
 |
|
|
194 |
Filed: 5/29/2015, Entered: None |
|
|
STIPULATION and [Proposed] Order Regarding Claim Construction of U.S. Patent No. RE44,186 by AstraZeneca AB. (Silver, Daniel) (Entered: 05/29/2015)
|
|
Request |
 |
|
|
193 |
Filed: 5/29/2015, Entered: None |
 |
|
SO ORDERED - re 192 STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to filed by Wockhardt USA LLC, Wockhardt Bio AG. Signed by Judge Gregory M. Sleet on 5/29/2015. (mdb) (Entered: 05/29/2015)
|
|
Request |
 |
|
|
192 |
Filed: 5/27/2015, Entered: None |
|
|
STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Riley, Richard) (Entered: 05/27/2015)
|
|
Request |
 |
|
|
191 |
Filed: 5/22/2015, Entered: None |
 |
|
SO ORDERED - re 189 STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to filed by Wockhardt USA LLC, Wockhardt Bio AG. Signed by Judge Gregory M. Sleet on 5/21/2015. (mdb) (Entered: 05/22/2015)
|
|
Request |
 |
|
|
190 |
Filed: 5/19/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff AstraZeneca AB's Preliminary Claim Construction of Certain Terms of U.S. Patent Nos. RE44,186 and 6,395,767 filed by AstraZeneca AB.(Silver, Daniel) (Entered: 05/19/2015)
|
|
Request |
 |
|
|
189 |
Filed: 5/18/2015, Entered: None |
|
|
STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to - filed by Wockhardt Bio AG, Wockhardt USA LLC. (Riley, Richard) (Entered: 05/18/2015)
|
|
Request |
 |
|
|
188 |
Filed: 5/18/2015, Entered: None |
|
|
NOTICE OF SERVICE of Wockhardt's Responses And Objections To AstraZeneca's Fourth Set Of Requests For Production Of Documents And Things (No. 45) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 05/18/2015)
|
|
Request |
 |
|
|
187 |
Filed: 5/15/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Preliminary Proposed Claim Constructions filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 05/15/2015)
|
|
Request |
 |
|
|
186 |
Filed: 5/13/2015, Entered: None |
 |
|
SO ORDERED - re 185 STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 5/12/2015. (mdb) (Entered: 05/13/2015)
|
|
Request |
 |
|
|
185 |
Filed: 5/8/2015, Entered: None |
|
|
STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 05/08/2015)
|
|
Request |
 |
|
|
184 |
Filed: 5/6/2015, Entered: None |
 |
|
SO ORDERED - re 182 STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 5/4/2015. (mdb) (Entered: 05/06/2015)
|
|
Request |
 |
|
|
183 |
Filed: 5/1/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Identification of Proposed Claim Terms for Construction filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 05/01/2015)
|
|
Request |
 |
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
182 |
Filed: 5/1/2015, Entered: None |
|
|
STIPULATION TO EXTEND TIME Between Plaintiff and Wockhardt to Extend Various Deadlines Related to the 400 Patent Only. See Stipulation for Details to - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 05/01/2015)
|
|
Request |
 |
|
|
181 |
Filed: 4/21/2015, Entered: None |
|
|
REDACTED VERSION of 166 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 04/21/2015)
|
|
Request |
 |
|
|
180 |
Filed: 4/21/2015, Entered: None |
|
|
REDACTED VERSION of 170 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 04/21/2015)
|
|
Request |
 |
|
|
179 |
Filed: 4/21/2015, Entered: None |
|
|
REDACTED VERSION of 169 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 04/21/2015)
|
|
Request |
 |
|
|
178 |
Filed: 4/20/2015, Entered: None |
|
|
REDACTED VERSION of 164 Stipulation by AstraZeneca AB. (Silver, Daniel) (Entered: 04/20/2015)
|
|
Request |
 |
|
|
177 |
Filed: 4/20/2015, Entered: None |
|
|
NOTICE of Counsel for Appellee AstraZeneca AB in Federal Circuit Appeal No. 15-1460 by AstraZeneca AB (Attachments: # 1 United States Court of Appeals for the Federal Circuit Entry of Appearance for Kannon K. Shanmugam, # 2 United States Court of Appeals for the Federal Circuit Entry of Appearance for Amy Mason Saharia, # 3 United States Court of Appeals for the Federal Circuit Entry of Appearance for Katherine Moran Meeks)(Silver, Daniel) (Entered: 04/20/2015)
|
|
Request |
 |
|
|
176 |
Filed: 4/20/2015, Entered: None |
|
|
REDACTED VERSION of 167 SO ORDERED,, Terminate Parties and Their Attorneys, by AstraZeneca AB. (Silver, Daniel) (Entered: 04/20/2015)
|
|
Request |
 |
|
|
175 |
Filed: 4/16/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney M. David Weingarten, Ph.D. - filed by AstraZeneca AB. (Attachments: # 1 Certification for M. David Weingarten, Ph.D.)(Silver, Daniel) (Entered: 04/16/2015)
|
|
Request |
 |
|
|
174 |
Filed: 4/16/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re (170 in 1:14-cv-00664-GMS) Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Watson filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/15/2015.This order has been emailed to local counsel. Associated Cases: 1:14-cv-00664-GMS, 1:14-cv-00666-GMS(mdb) (Entered: 04/16/2015)
|
|
Request |
 |
|
|
173 |
Filed: 4/16/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 169 Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Actavis filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/15/2015.This order has been emailed to local counsel. (mdb) (Entered: 04/16/2015)
|
|
Request |
 |
|
|
172 |
Filed: 4/16/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 166 Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Mylan filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/15/2015.This order has been emailed to local counsel. (mdb) (Entered: 04/16/2015)
|
|
Request |
 |
|
|
171 |
Filed: 4/15/2015, Entered: None |
|
|
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (mdb) (Entered: 04/15/2015)
|
|
Request |
 |
|
|
170 |
Filed: 4/14/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Watson by AstraZeneca AB. (Silver, Daniel) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
169 |
Filed: 4/14/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Actavis by AstraZeneca AB. (Silver, Daniel) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
168 |
Filed: 4/14/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 164 Stipulation of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Par. Party Par Pharmaceutical Inc. terminated. Attorney Michael J. Freno; Peter Giunta; Katharine Crawford Lester; Michael S. Chang and Steven J. Fineman terminated. Signed by Judge Gregory M. Sleet on 4/14/2015.This order has been emailed to local counsel. (mdb) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
167 |
Filed: 4/14/2015, Entered: None |
 |
|
[SEALED] SO ORDERED - re 159 Stipulation and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Teva. Party Teva Pharmaceuticals USA Inc. terminated. Attorney Sarah M. Stensland; Mark D. Schuman and John W. Shaw terminated. Signed by Judge Gregory M. Sleet on 4/14/2015.This order has been emailed to local counsel. (mdb) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
166 |
Filed: 4/14/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Mylan by AstraZeneca AB. (Silver, Daniel) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
165 |
Filed: 4/14/2015, Entered: None |
 |
|
SO ORDERED - re 154 Stipulation of Dismissal Without Prejudice of Formulation Patent Claims (U.S. Patent No. 7,951,400) Between AstraZeneca and Glenmark filed by AstraZeneca AB, Party Glenmark Generics Inc. USA and Glenmark Generics Ltd. terminated. Attorney John W. Shaw; Shashank Upadhye; Michael Baniak and Karen Elizabeth Keller terminated. Signed by Judge Gregory M. Sleet on 4/14/2015. (mdb) (Entered: 04/14/2015)
|
|
Request |
 |
|
|
164 |
Filed: 4/13/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and [Proposed] Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Par by AstraZeneca AB. (Silver, Daniel) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
163 |
Filed: 4/13/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's [Confidential] Fourth Set of Requests to Wockhardt for the Production of Documents and Things (No. 45) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
162 |
Filed: 4/13/2015, Entered: None |
 |
|
SO ORDERED - re 153 Stipulation re: motion for summary judgment briefing schedule filed by Par Pharmaceutical Inc. Signed by Judge Gregory M. Sleet on 4/13/2015. (mdb) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
161 |
Filed: 4/13/2015, Entered: None |
 |
|
SO ORDERED - re 152 Stipulation of Dismissal of Formulation Patent Claims U.S. Patent Nos. 7,951,400 AND 8,628,799 filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/13/2015. (mdb) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
160 |
Filed: 4/13/2015, Entered: None |
 |
|
SO ORDERED - re 151 Stipulation of Dismissal DISMISSING WITHOUTPREJUDICE ALL CLAIMS AND COUNTERCLAIMS CONCERNINGU.S. PATENT NOS. 7,951,400 AND 8,628,799 filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/13/2015. (mdb) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
159 |
Filed: 4/13/2015, Entered: None |
|
|
[SEALED] Joint STIPULATION and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Teva by AstraZeneca AB. (Silver, Daniel) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
158 |
Filed: 4/13/2015, Entered: None |
|
|
NOTICE requesting Clerk to remove John K. Hsu as co-counsel. Reason for request: No Longer Affiliated with Winston & Strawn LLP. (Phillips, John) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
157 |
Filed: 4/13/2015, Entered: None |
|
|
NOTICE requesting Clerk to remove John K. Hsu as co-counsel. Reason for request: No Longer Affiliated with Winston & Strawn LLP. (Phillips, John) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
156 |
Filed: 4/13/2015, Entered: None |
 |
|
SO ORDERED - re 150 Stipulation of Dismissal filed by AstraZeneca AB, Party Apotex Corp. and Apotex Inc. terminated. Attorney W. Blake Coblentz; Barry P. Golob; Aaron S. Lukas; Kerry B. McTigue; Joseph James Bellew and Ryan P. Bottegal terminated. Signed by Judge Gregory M. Sleet on 4/9/2015. (mdb) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
155 |
Filed: 4/13/2015, Entered: None |
 |
|
SO ORDERED - re 149 Stipulation of Dismissal of Formulation Patent Claims Concerning U.S. Patent No. 7,951,400 Between AstraZeneca and Aurobindo filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 4/13/2015. (mdb) (Entered: 04/13/2015)
|
|
Request |
 |
|
|
154 |
Filed: 4/10/2015, Entered: None |
|
|
STIPULATION Stipulation and Proposed Order of Dismissal Without Prejudice of Formulation Patent Claims Between AstraZeneca and Glenmark by AstraZeneca AB. (Silver, Daniel) (Entered: 04/10/2015)
|
|
Request |
 |
|
|
153 |
Filed: 4/10/2015, Entered: None |
|
|
STIPULATION re: motion for summary judgment briefing schedule by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 04/10/2015)
|
|
Request |
 |
|
|
152 |
Filed: 4/10/2015, Entered: None |
|
|
STIPULATION of Dismissal of Formulation Patent Claims Between AstraZeneca and Sun by AstraZeneca AB. (Silver, Daniel) (Entered: 04/10/2015)
|
|
Request |
 |
|
|
151 |
Filed: 4/10/2015, Entered: None |
|
|
STIPULATION of Dismissal of Formulation Patent Claims Between AstraZeneca and Amneal by AstraZeneca AB. (Silver, Daniel) (Entered: 04/10/2015)
|
|
Request |
 |
|
|
150 |
Filed: 4/9/2015, Entered: None |
|
|
STIPULATION of Dismissal of Formulation Patent Claims Between AstraZeneca and Apotex by AstraZeneca AB. (Silver, Daniel) (Entered: 04/09/2015)
|
|
Request |
 |
|
|
149 |
Filed: 4/8/2015, Entered: None |
|
|
STIPULATION of Dismissal of Formulation Patent Claims Between AstraZeneca and Aurobindo by AstraZeneca AB. (Silver, Daniel) (Entered: 04/08/2015)
|
|
Request |
 |
|
|
148 |
Filed: 3/30/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff AstraZeneca AB's Initial Infringement Contentions Directed to Wockhardt filed by AstraZeneca AB.(Silver, Daniel) (Entered: 03/30/2015)
|
|
Request |
 |
|
|
147 |
Filed: 3/18/2015, Entered: None |
|
|
NOTICE of Docketing Record on Appeal from USCA for the Federal Circuit - re 146 USCA Order. USCA Case Number 15-1460 (mdb) (Entered: 03/18/2015)
|
|
Request |
 |
|
|
146 |
Filed: 3/17/2015, Entered: None |
|
|
ORDER of USCA. Decision of USCA: The petition for permission to appeal is granted. (mdb) (Entered: 03/17/2015)
|
|
Request |
 |
|
|
145 |
Filed: 3/13/2015, Entered: None |
|
|
NOTICE OF SERVICE of Notice of service of Defendants prior art references filed by Amneal Pharmaceuticals LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 03/13/2015)
|
|
Request |
 |
|
|
144 |
Filed: 3/12/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Joint Initial Invalidity Contentions regarding U.S. Patent No. RE 44,186 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 03/12/2015)
|
|
Request |
 |
|
|
143 |
Filed: 3/9/2015, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiff's Objections and Responses to Apotex Inc.'s and Apotex Corp.'s First Set of Interrogatories (Nos. 1-5), and (2) Plaintiff's Objections and Responses to Apotex Inc.'s and Apotex Corp.'s First Set of Requests for the Production of Documents and Things (Nos. 1-6) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 03/09/2015)
|
|
Request |
 |
|
|
142 |
Filed: 3/9/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's [Confidential] Supplemental Response to Defendants' Interrogatories No.1 filed by AstraZeneca AB.(Silver, Daniel) (Entered: 03/09/2015)
|
|
Request |
 |
|
|
141 |
Filed: 3/2/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Elham Firouzi Steiner - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 03/02/2015)
|
|
Request |
 |
|
|
140 |
Filed: 2/27/2015, Entered: None |
|
|
NOTICE requesting Clerk to remove Joshua A. Mack as co-counsel. Reason for request: no longer with Wilson Sonsini Goodrich & Rosati P.C.. (Palapura, Bindu) (Entered: 02/27/2015)
|
|
Request |
 |
|
|
139 |
Filed: 2/19/2015, Entered: None |
 |
|
SO ORDERED - re 138 Stipulation filed by Actavis Laboratories FL Inc., Watson Laboratories Inc. The Discovery Conference scheduled for 2/19/2015 at 3:00 PM is CANCELLED. Signed by Judge Gregory M. Sleet on 2/19/2015. (mdb) (Entered: 02/19/2015)
|
|
Request |
 |
|
|
138 |
Filed: 2/18/2015, Entered: None |
|
|
STIPULATION and Order Regarding the Schedule for Initial Infringement and Invalidity Contentions for U.S. Patent Nos. 7,951,400 and 8,628,799 by Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 02/18/2015)
|
|
Request |
 |
|
|
137 |
Filed: 2/17/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Ryan P. Bottegal - filed by Apotex Corp., Apotex Inc.. (Bellew, Joseph) (Entered: 02/17/2015)
|
|
Request |
 |
|
|
136 |
Filed: 2/9/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's Objections and Responses to Par Pharmaceutical, Inc.'s First Set of Interrogatories (No.1) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 02/09/2015)
|
|
Request |
 |
|
|
135 |
Filed: 2/9/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop - filed by AstraZeneca AB. (Attachments: # 1 Certification for Charles E. Lipsey, # 2 Certification for James B. Monroe, # 3 Certification for Robert F. Shaffer, # 4 Certification for Maximilienne Bishop)(Silver, Daniel) (Entered: 02/09/2015)
|
|
Request |
 |
|
|
134 |
Filed: 2/6/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Watson Laboratories, Inc. and Actavis Laboratories FL, Inc.s Objections and Responses to Plaintiff AstraZeneca ABs Amended First and Second Sets of Interrogatories (Nos. 1-8), and First Supplemental Response to Original Interrogatories (No. 5), and Defendants Watson Laboratories, Inc. and Actavis Laboratories FL, Inc.s Objections and Responses to Plaintiff AstraZeneca ABs Amended First and Second Sets of Requests for the Production of Documents and Things (Nos. 1-10, 12-13) and First Supplemental Response to Original Requests for Production (No. 1) filed by Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 02/06/2015)
|
|
Request |
 |
|
|
133 |
Filed: 2/4/2015, Entered: None |
|
|
NOTICE OF SERVICE of Wockhardt's Supplemental Answers And Objections To Plaintiff's First Set Of Interrogatories (Nos. 1-7) [Corrected] filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 02/04/2015)
|
|
Request |
 |
|
|
132 |
Filed: 2/3/2015, Entered: None |
|
|
NOTICE OF SERVICE of Apotex Corp. and Apotex, Inc.'s First Set of Interrogatories (Nos. 1-5) to Plaintiff and Apotex Corp. and Apotex, Inc.'s First Set of Requests for the Production of Documents and Things (Nos. 1-6) to Plaintiff filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 02/03/2015)
|
|
Request |
 |
|
|
131 |
Filed: 1/30/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Peter S. Kang of Wilson Sonsini Goodrich & Rosati - filed by Mylan Pharmaceuticals Inc.. (Moore, David) (Entered: 01/30/2015)
|
|
Request |
 |
|
|
130 |
Filed: 1/29/2015, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff AstraZeneca AB's Initial Infringement Contentions Directed to Defendants filed by AstraZeneca AB.(Silver, Daniel) (Entered: 01/29/2015)
|
|
Request |
 |
|
|
129 |
Filed: 1/28/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Response to Plaintiff's Third Set of Requests for the Production of Documents and Things (Nos. 14-45) filed by Glenmark Generics Inc. USA, Glenmark Generics Ltd..(Shaw, John) (Entered: 01/28/2015)
|
|
Request |
 |
|
|
128 |
Filed: 1/27/2015, Entered: None |
 |
|
SO ORDERED - re (125 in 1:14-cv-00664-GMS, 9 in 1:14-cv-01356-GMS) Stipulation of Dismissal filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 1/27/2015. (mdb) (Entered: 01/27/2015)
|
|
Request |
 |
|
|
127 |
Filed: 1/27/2015, Entered: None |
 |
|
SO ORDERED - re (22 in 1:14-cv-00666-GMS, 18 in 1:14-cv-01051-GMS, 124 in 1:14-cv-00664-GMS) Stipulation of Dismissal filed by AstraZeneca AB. Signed by Judge Gregory M. Sleet on 1/27/2015. (mdb) (Entered: 01/27/2015)
|
|
Request |
 |
|
|
126 |
Filed: 1/27/2015, Entered: None |
 |
|
SO ORDERED - re (115 in 1:14-cv-00664-GMS, 12 in 1:14-cv-01469-GMS) Stipulation of Consolidation. Cases are consolidated for all purposes. All future filings shall be made ONLY IN CA 14-CV-664 GMS. The parties shall comply with Scheduling Order (DI 26 in CA 14-664) entered on 10/20/2014. Signed by Judge Gregory M. Sleet on 1/26/2015. Associated Cases: 1:14-cv-01469-GMS, 1:14-cv-00664-GMS(mdb) (Entered: 01/27/2015)
|
|
Request |
 |
|
|
125 |
Filed: 1/27/2015, Entered: None |
|
|
STIPULATION of Dismissal Stipulation and [Proposed] Order of Dismissal Without Prejudice and Amending Caption (Dismissing Defendants Watson Laboratories, Inc., Actavis, Inc. and Actavis LLC from C.A. No. 14-1356) by AstraZeneca AB. (Silver, Daniel) (Entered: 01/27/2015)
|
|
Request |
 |
|
|
124 |
Filed: 1/27/2015, Entered: None |
|
|
STIPULATION of Dismissal Stipulation and [Proposed] Order of Dismissal Without Prejudice and Amending Caption (Dismissing Defendants Actavis, Inc. and Actavis LLC from C.A. Nos. 14-666 & 14-1051) by AstraZeneca AB. (Silver, Daniel) (Entered: 01/27/2015)
|
|
Request |
 |
|
|
123 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Responses to Plaintiff's Third Set of Requests for Production of Documents and Things (Nos. 14-45) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
122 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's Third Set of Requests to Sun for Production of Documents and Things filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
121 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Amneal Pharmaceuticals LLC's Responses and Objections to Plaintiff's Third Set of Requests to Amneal for Production of Documents and Things filed by Amneal Pharmaceuticals LLC.(Bilson, David) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
120 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Watson Laboratories, Inc., Actavis, Inc., And Actavis LLCs Objections and Responses to Plaintiff AstraZeneca ABs Third Set of Requests for the Production of Documents and Things (Nos. 14-45) filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
119 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiff's Third Set of Requests for the Production of Documents and Things (Nos. 17-48) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
118 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Defendant's Response to Plaintiff's Third Set of Requests for the Production of Documents and Things (Nos. 14-45) filed by Teva Pharmaceuticals USA Inc..(Keller, Karen) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
117 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Wockhardt's Responses And Objections To AstraZeneca's Third Set Of Requests For Production Of Documents And Things (Nos. 14-44) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
116 |
Filed: 1/26/2015, Entered: None |
|
|
NOTICE OF SERVICE of Apotex Corp.'s and Apotex, Inc.'s Objections and Responses to Plaintiffs Third Set of Requests for the Production of Documents and Things (Nos. 15-46) filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 01/26/2015)
|
|
Request |
 |
|
|
115 |
Filed: 1/23/2015, Entered: None |
|
|
STIPULATION and [Proposed] Order of Consolidation by AstraZeneca AB. (Silver, Daniel) (Entered: 01/23/2015)
|
|
Request |
 |
|
|
114 |
Filed: 1/22/2015, Entered: None |
|
|
NOTICE OF SERVICE of Aurobindo's Responses to Plaintiff's Third Set of Requests for Production (Nos. 15-46) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 01/22/2015)
|
|
Request |
 |
|
|
113 |
Filed: 1/14/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Mark D. Schuman and Sarah M. Stensland - filed by Glenmark Generics Inc. USA, Glenmark Generics Ltd.. (Shaw, John) (Entered: 01/14/2015)
|
|
Request |
 |
|
|
112 |
Filed: 1/14/2015, Entered: None |
|
|
NOTICE OF SUBSTITUTION OF COUNSEL re Glenmark Generics Inc. USA, Glenmark Generics Ltd.: Entry of appearance of attorney John W. Shaw. Attorney Adam W. Poff and James L. Higgins terminated. (Shaw, John) (Entered: 01/14/2015)
|
|
Request |
 |
|
|
111 |
Filed: 1/13/2015, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Harold M. Storey - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 01/13/2015)
|
|
Request |
 |
|
|
110 |
Filed: 1/12/2015, Entered: None |
|
|
NOTICE OF SERVICE of [Confidential] Plaintiff's Objections and Responses to Defendants' Second Set of Joint Interrogatories (Nos. 8-11) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 01/12/2015)
|
|
Request |
 |
|
|
109 |
Filed: 1/9/2015, Entered: None |
|
|
NOTICE requesting Clerk to remove Stephanie E. O'Byrne as co-counsel.. (Keller, Karen) (Entered: 01/09/2015)
|
|
Request |
 |
|
|
108 |
Filed: 1/9/2015, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s First Set of Interrogatories (No.1) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 01/09/2015)
|
|
Request |
 |
|
|
107 |
Filed: 12/23/2014, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's Third Set of Requests for Production of Documents and Things filed by AstraZeneca AB.(Silver, Daniel) (Entered: 12/23/2014)
|
|
Request |
 |
|
|
106 |
Filed: 12/22/2014, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiff's Objections and Responses to Defendant Tevas First Set of Interrogatories (No. 1) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 12/22/2014)
|
|
Request |
 |
|
|
105 |
Filed: 12/19/2014, Entered: None |
|
|
MOTION for Protective Order Stipulated Protective Order Pursuant to Federal Rule of Civil Procedure 26(c) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 12/19/2014)
|
|
Request |
 |
|
|
104 |
Filed: 12/19/2014, Entered: None |
|
|
NOTICE requesting Clerk to remove James F. Hurst as co-counsel. Reason for request: He is no longer affiliated with Winston & Strawn LLP. (Phillips, John) (Entered: 12/19/2014)
|
|
Request |
 |
|
|
103 |
Filed: 12/17/2014, Entered: None |
 |
|
ORDER - granting 63 Mylan Pharmaceuticals Inc.'s Motion for Certification for Interlocutory Appeal . Signed by Judge Gregory M. Sleet on 12/17/2014. (mdb) (Entered: 12/17/2014)
|
|
Request |
 |
|
|
102 |
Filed: 12/15/2014, Entered: None |
|
|
NOTICE OF SERVICE of Plaintiffs Objections And Responses To Defendants First Set Of Individualized Interrogatories (NOS. 1-4) [Highly Confidential Pursuant To Local Rule 26.2 Outside Counsels Eyes Only] filed by AstraZeneca AB.(Silver, Daniel) (Entered: 12/15/2014)
|
|
Request |
 |
|
|
101 |
Filed: 12/15/2014, Entered: None |
|
|
REPLY BRIEF re 63 MOTION Mylan Pharmaceuticals Inc.'s Motion for Certification for Interlocutory Appeal filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Main Document 101 replaced on 12/16/2014) (mdb). (Entered: 12/15/2014)
|
|
Request |
 |
|
|
100 |
Filed: 12/15/2014, Entered: None |
|
|
Joint STIPULATION TO EXTEND TIME for the Parties to Submit a [Proposed] Stipulated Protective Order to Friday, December 19, 2014 (from Monday, December 15, 2014) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 12/15/2014)
|
|
Request |
 |
|
|
99 |
Filed: 12/11/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Michael S. Chang - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 12/11/2014)
|
|
Request |
 |
|
|
98 |
Filed: 12/10/2014, Entered: None |
|
|
NOTICE OF SERVICE of Apotex Corp. and Apotex, Inc.'s Initial Disclosures pursuant to Paragraph 3 of District of Delaware's Default Standard for Discovery filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 12/10/2014)
|
|
Request |
 |
|
|
97 |
Filed: 12/10/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories Nos. 8-11 filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 12/10/2014)
|
|
Request |
 |
|
|
96 |
Filed: 12/10/2014, Entered: None |
|
|
ANSWER to 70 Answer to Complaint, Counterclaim by AstraZeneca AB.(Silver, Daniel) (Entered: 12/10/2014)
|
|
Request |
 |
|
|
95 |
Filed: 12/8/2014, Entered: None |
|
|
Joint STIPULATION TO EXTEND TIME for the Parties to Submit a [Proposed] Stipulated Protective Order to Monday, December 15, 2014 (from Monday, December 8, 2014) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 12/08/2014)
|
|
Request |
 |
|
|
94 |
Filed: 12/4/2014, Entered: None |
|
|
ANSWERING BRIEF in Opposition re 63 MOTION Mylan Pharmaceuticals Inc.'s Motion for Certification for Interlocutory Appeal filed by AstraZeneca AB.Reply Brief due date per Local Rules is 12/15/2014. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 12/04/2014)
|
|
Request |
 |
|
|
93 |
Filed: 12/3/2014, Entered: None |
|
|
Joint STIPULATION TO EXTEND TIME to File Stipulated Protective Order to December 8, 2014 - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 12/03/2014)
|
|
Request |
 |
|
|
92 |
Filed: 12/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of Confidential Samples of Defendant Mylan Pharmaceuticals, Inc.'s ANDA Products filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 12/03/2014)
|
|
Request |
 |
|
|
91 |
Filed: 12/1/2014, Entered: None |
|
|
NOTICE OF SERVICE of Samples of Apotex Corp. and Apotex Inc.'s ANDA products filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 12/01/2014)
|
|
Request |
 |
|
|
90 |
Filed: 11/26/2014, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Amended Initial Disclosures filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/26/2014)
|
|
Request |
 |
|
|
89 |
Filed: 11/26/2014, Entered: None |
|
|
NOTICE OF SERVICE of Confidential Samples of Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.'s ANDA Products filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 11/26/2014)
|
|
Request |
 |
|
|
88 |
Filed: 11/26/2014, Entered: None |
|
|
NOTICE OF SERVICE of Samples of Watson Laboratories Inc.'s and Actavis Laboratories FL, Inc.'s ANDA Products filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/26/2014)
|
|
Request |
 |
|
|
87 |
Filed: 11/26/2014, Entered: None |
|
|
NOTICE OF SERVICE of Confidential Samples of Defendant Amneal Pharmaceuticals LLC's ANDA Products filed by Amneal Pharmaceuticals LLC.(Bilson, David) (Entered: 11/26/2014)
|
|
Request |
 |
|
|
86 |
Filed: 11/26/2014, Entered: None |
|
|
NOTICE OF SERVICE of samples of Par Pharmaceutical, Inc.'s ANDA products filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/26/2014)
|
|
Request |
 |
|
|
85 |
Filed: 11/25/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Watson Laboratories, Inc., Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis LLC's Core Technical Documents filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/25/2014)
|
|
Request |
 |
|
|
84 |
Filed: 11/25/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Ralph J. Gabric, Laura A. Lydigsen and Yun Wei - filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 11/25/2014)
|
|
Request |
 |
|
|
83 |
Filed: 11/24/2014, Entered: None |
|
|
NOTICE OF SERVICE of samples of Aurobindo's ANDA products filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 11/24/2014)
|
|
Request |
 |
|
|
| Save 25% on a pre-paid one year subscription. |
|
|
82 |
Filed: 11/24/2014, Entered: None |
|
|
Joint STIPULATION TO EXTEND TIME to File Stipulated Protective Order to December 3, 2014 - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 11/24/2014)
|
|
Request |
 |
|
|
81 |
Filed: 11/24/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to Defendants First Set of Requests for the Production of Documents and Things (Nos. 1-97); and (2) Plaintiffs Objections and Responses to Defendants First Set of Interrogatories (Nos. 1-7) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 11/24/2014)
|
|
Request |
 |
|
|
80 |
Filed: 11/20/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories to Plaintiff (No. 1) filed by Teva Pharmaceuticals USA Inc..(Shaw, John) (Entered: 11/20/2014)
|
|
Request |
 |
|
|
79 |
Filed: 11/20/2014, Entered: None |
|
|
NOTICE OF SERVICE of Glenmark's Rule 26 Initial Disclosures and Local Rule Para. 3 Disclosures filed by Glenmark Generics Inc. USA, Glenmark Generics Ltd..(Higgins, James) (Entered: 11/20/2014)
|
|
Request |
 |
|
|
78 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (2) Plaintiffs Rule 26(a)(1)(A) Initial Disclosures filed by AstraZeneca AB.(Silver, Daniel) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
77 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of Mylan's Initial Disclosures Pursuant to D. Del's Default Standard for Discovery and Mylan's Rule 26(a) Initial Disclosures filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
76 |
Filed: 11/19/2014, Entered: None |
|
|
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan Inc. for Mylan Pharmaceuticals Inc. filed by Mylan Pharmaceuticals Inc.. (Palapura, Bindu) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
75 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Initial Disclosures and Par Pharmaceutical, Inc.'s Paragraph 3 Disclosures filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
74 |
Filed: 11/19/2014, Entered: None |
|
|
ANSWER to Complaint by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
73 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendants Watson Laboratories, Inc., Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis LLC's Initial Disclosures Pursuant To Fed. R. Civ. P. 26(a)(1) and Paragraph 3 Of The District Of Delaware Default Standard For Discovery filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
72 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of Apotex Corp. and Apotex, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26 filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
71 |
Filed: 11/19/2014, Entered: None |
|
|
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Actavis Inc. for Actavis LLC, Watson Laboratories Inc.; Corporate Parent Andrz Corporation for Actavis Laboratories FL Inc.; Corporate Parent Actavis plc for Actavis Inc. filed by Actavis Inc., Actavis LLC, Actavis Laboratories FL Inc., Watson Laboratories Inc.. (Gattuso, Dominick) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
70 |
Filed: 11/19/2014, Entered: None |
|
|
ANSWER to 1 Complaint, with Jury Demand , COUNTERCLAIM against AstraZeneca AB by Watson Laboratories Inc., Actavis LLC, Actavis Inc., Actavis Laboratories FL Inc..(Gattuso, Dominick) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
69 |
Filed: 11/19/2014, Entered: None |
 |
|
SO ORDERED - re (56 in 1:14-cv-00664-GMS, 7 in 1:14-cv-01356-GMS) Stipulation and Proposed Order of Consolidation filed by AstraZeneca AB. These cases are consolidated for all purposes. ALL FUTURE FILINGS PERTAINING TO CA 14-1356 GMS SHALL BE MADE ONLY CA 14-664 GMS. Signed by Judge Gregory M. Sleet on 11/18/2014. (mdb) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
68 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of Initial Disclosures Of Defendants Wockhardt Bio AG And Wockhardt USA, LLC Pursuant To Rule 26(a)(1) and Initial E-Discovery Disclosures Of Defendants Wockhardt Bio AG And Wockhardt USA, LLC Pursuant To Delaware Default Standard filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
67 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Aurobindo's Paragraph 3 Disclosures; and (2) Aurobindo's Rule 26 Initial Disclosures filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
66 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of 1. Defendant Teva Pharmaceuticals USA, Inc.'s Initial Disclosures under the Default Standard for Discovery and 2. Defendant Teva Pharmaceuticals USA, Inc.'s Initial Disclosures Under Rule 26(a)(1) filed by Teva Pharmaceuticals USA Inc..(O'Byrne, Stephanie) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
65 |
Filed: 11/19/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.s Rule 26(a)(1) Initial Disclosures; (2) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.s Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery; (3) Defendant Amneal Pharmaceuticals LLCs Rule 26(a)(1) Initial Disclosures; and (4) Defendant Amneal Pharmaceuticals LLCs Initial Disclosures Under Paragraph 3 of the Default Standard for Discovery filed by Amneal Pharmaceuticals LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Phillips, John) (Entered: 11/19/2014)
|
|
Request |
 |
|
|
64 |
Filed: 11/17/2014, Entered: None |
|
|
OPENING BRIEF in Support re 63 MOTION Mylan Pharmaceuticals Inc.'s Motion for Certification for Interlocutory Appeal filed by Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 12/4/2014. (Horwitz, Richard) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
63 |
Filed: 11/17/2014, Entered: None |
|
|
MOTION Mylan Pharmaceuticals Inc.'s Motion for Certification for Interlocutory Appeal - filed by Mylan Pharmaceuticals Inc.. (Horwitz, Richard) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
62 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiff's First Set of Interrogatories (No. 8); and Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things (No. 16) filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
61 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Responses to Plainittf's First Set of Requests for Production of Documents and Things (Nos. 1-12) and Par Pharmaceutical, Inc.'s Responses to Plaintiff's Second Set of Requests for Production of Documents and Things (No. 13) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
60 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of Par Pharmaceutical, Inc.'s Objections and Responses to Plainittf's First Set of Interrogotories (Nos. 1-7) and Par Pharmaceutical, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (No. 8) filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
59 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of Wockhardt's Answers And Objections To Astrazeneca's Second Set Of Interrogatories (No. 8) and Wockhardt's Responses And Objections To Astrazeneca's Second Set Of Requests For Production Of Documents And Things (No. 13) filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
58 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of Apotex, Corp. and Apotex, Inc.'s Objections and Responses to Plaintiff's Second Set of Interrogatories (No. 8); and Apotex, Corp and Apotex, Inc.'s Objections and Responses to Plaintiff's Second Set Of Requests For The Production Of Documents And Things (Nos.14) filed by Apotex Corp., Apotex Inc..(Bellew, Joseph) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
57 |
Filed: 11/17/2014, Entered: None |
|
|
STIPULATION TO EXTEND TIME for the Parties to Submit a [Proposed] Stipulated Protective Order to Monday, November 24, 2014 (from Monday, November 17, 2014) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
56 |
Filed: 11/17/2014, Entered: None |
|
|
STIPULATION and [Proposed] Order of Consolidation by AstraZeneca AB. (Silver, Daniel) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
55 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendant's Response to Plaintiff's Second Set of Requests For The Production of Documents and Things (No. 13) (2) Defendant's Response to Plaintiff's Second Set of Interrogatories (No. 8) filed by Teva Pharmaceuticals USA Inc..(O'Byrne, Stephanie) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
54 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendants Watson Laboratories, Inc., Actavis, Inc., And Actavis LLC's Objections and Responses to Plaintiff AstraZeneca AB's Second Set of Interrogatories (No. 8); and (2) Defendants Watson Laboratories, Inc., Actavis, Inc., and Actavis LLC's Objections and Responses to Plaintiff AstraZeneca AB's Second Set of Requests for the Production Of Documents and Things (No. 13) filed by Actavis Inc., Actavis LLC, Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
53 |
Filed: 11/17/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.s Responses and Objections to Plaintiffs Second Set of Requests to Sun for Production of Documents and Things; (2) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.s Responses and Objections to Plaintiffs Second Set of Interrogatories to Sun; (3) Defendant Amneal Pharmaceuticals LLCs Responses and Objections to Plaintiffs Second Set of Requests to Amneal for Production of Documents and Things; and (4) Defendant Amneal Pharmaceuticals LLCs Responses and Objections to Plaintiffs Second Set of Interrogatories to Amneal filed by Amneal Pharmaceuticals LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 11/17/2014)
|
|
Request |
 |
|
|
52 |
Filed: 11/13/2014, Entered: None |
|
|
NOTICE OF SERVICE of Objections and Responses to Plaintiff's Second Set of Interrogatories and Objections and Responses to Plaintiff's Second Set of Requests for the Production of Documents and Things filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 11/13/2014)
|
|
Request |
 |
|
|
51 |
Filed: 11/13/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Watson Laboratories, Inc., Actavis, Inc., and Actavis LLC's First Set of Individualized Interrogatories (Nos. 1-4) to Plaintiff AstraZeneca AB filed by Actavis Inc., Actavis LLC, Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/13/2014)
|
|
Request |
 |
|
|
50 |
Filed: 11/13/2014, Entered: None |
|
|
NOTICE OF SUBSTITUTION OF COUNSEL re Apotex Corp., Apotex Inc.: Entry of appearance of attorney Joseph James Bellew. Attorney Damien Nicholas Tancredi terminated. (Bellew, Joseph) (Entered: 11/13/2014)
|
|
Request |
 |
|
|
49 |
Filed: 11/11/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Peter Giunta - filed by Par Pharmaceutical Inc.. (Lester, Katharine) (Entered: 11/11/2014)
|
|
Request |
 |
|
|
48 |
Filed: 11/11/2014, Entered: None |
|
|
NOTICE of Change of Firm Affiliation of Out-Of-State Pro Hac Vice Counsel by Par Pharmaceutical Inc. (Lester, Katharine) (Entered: 11/11/2014)
|
|
Request |
 |
|
|
47 |
Filed: 11/10/2014, Entered: None |
|
|
STIPULATION TO EXTEND TIME The Deadline for Parties to Submit a [Proposed] Stipulated Protective Order to Monday, November 17, 2014 (from Monday, November 10, 2014) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 11/10/2014)
|
|
Request |
 |
|
|
46 |
Filed: 11/10/2014, Entered: None |
|
|
MOTION for Protective Order Stipulated Interim Protectvie Order for Disclosure of Confidential Information to Outside Counsultants - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 11/10/2014)
|
|
Request |
 |
|
|
45 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of 1) Answers to Plaintiff's First Set of Interrogatories to Glenmark (Nos. 1-7); 2) Answer to Plaintiff's Second Set of Interrogatories to Glenmark (No. 8); 3) Responses to Plaintiff's First Set of Requests to Glenmark for the Production of Documents and Things (Nos. 1-12), and 4) Response to Plaintiff's Second Set of Requests to Glenmark for the Production of Documents and Things (No. 13) filed by Glenmark Generics Inc. USA, Glenmark Generics Ltd..(Higgins, James) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
44 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of Apotex, Corp and Apotex, Inc.'s Objections and Responses to Plaintiff's First Set Of Interrogatories (Nos. 1-7); and Apotex, Corp and Apotex, Inc.'s Objections and Responses to Plaintiff's First Set Of Requests For The Production Of Documents And Things (Nos. 1-13) filed by Apotex Corp., Apotex Inc..(Tancredi, Damien) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
43 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendants Watson Laboratories, Inc., Actavis, Inc. And Actavis LLC's Objections and Responses to Plaintiff AstraZeneca AB's First Set of Interrogatories (Nos. 1-7); and (2) Defendants Watson Laboratories, Inc., Actavis, Inc. And Actavis LLC's Objections and Responses to Plaintiff AstraZeneca AB's First Set of Requests for The Production Of Documents and Things (Nos. 1-12) filed by Actavis Inc., Actavis LLC, Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
42 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals Inc.'s Objections And Responses To Plaintiff's First Set Of Requests For The Production Of Documents And Things (Nos. 1-15); and Mylan Pharmaceuticals Inc.'s Objections And Responses To Plaintiff's First Set Of Interrogatories (Nos. 1-7) filed by Mylan Pharmaceuticals Inc..(Moore, David) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
41 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Interrogatories to Sun and (2) Defendants Sun Pharma Global FZE and Sun Pharmaceutical Industries Ltd.'s Responses and Objections to Plaintiff's First Set of Requests to Sun for Production of Documents and Things filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
40 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendant Amneal Pharmaceuticals LLC's Responses and Objections to Plaintiff's First Set of Interrogatories to Amneal and (2) Defendant Amneal Pharmaceuticals LLC's Responses and Objections to Plaintiff's First Set of Requests to Amneal for Production of Documents and Things filed by Amneal Pharmaceuticals LLC.(Bilson, David) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
39 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Defendant Teva Pharmaceutical USA, Inc.'s Response to Plaintiff's First Set of Interrogatories (Nos. 1-7) (2) Defendant Teva Pharmaceutical USA, Inc.'s Response to Plaintiff's First Set of Requests for the Production of Documents and Things (Nos. 1-12) filed by Teva Pharmaceuticals USA Inc..(Shaw, John) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
38 |
Filed: 11/3/2014, Entered: None |
|
|
NOTICE OF SERVICE of Wockhardt's Responses And Objections To AstraZeneca's First Set Of Requests For Production Of Documents And Things (Nos. 1-12) [Corrected] and Wockhardt's Answers And Objections To Plaintiff's First Set Of Interrogatories (Nos. 1-7) [Corrected] filed by Wockhardt Bio AG, Wockhardt USA LLC.(Riley, Richard) (Entered: 11/03/2014)
|
|
Request |
 |
|
|
37 |
Filed: 10/31/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendant Par Pharmaceutical, Inc.'s Core Technical Documents filed by Par Pharmaceutical Inc..(Lester, Katharine) (Entered: 10/31/2014)
|
|
Request |
 |
|
|
36 |
Filed: 10/31/2014, Entered: None |
|
|
NOTICE OF SERVICE of Mylan Pharmaceuticals, Inc.'s Core Technical Documents [Highly Confidential - Outside Counsel Only] filed by Mylan Pharmaceuticals Inc..(Palapura, Bindu) (Entered: 10/31/2014)
|
|
Request |
 |
|
|
35 |
Filed: 10/31/2014, Entered: None |
|
|
NOTICE OF SERVICE of Apotex Corp. and Apotex Inc. Production of Core Technical Documents filed by Apotex Corp., Apotex Inc..(Tancredi, Damien) (Entered: 10/31/2014)
|
|
Request |
 |
|
|
34 |
Filed: 10/31/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Amneal Pharmaceuticals, LLC's Core Technical Documents and (2) Sun Pharma Global FZE and Sun Pharmaceutical Industries, Ltd.'s Core Technical Documents filed by Amneal Pharmaceuticals LLC, Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd..(Bilson, David) (Entered: 10/31/2014)
|
|
Request |
 |
|
|
33 |
Filed: 10/31/2014, Entered: None |
|
|
NOTICE OF SERVICE of Defendants' Core Technical Documents Pursuant To Paragraph 3 of The Delaware Default E-Discovery Standard filed by Actavis Inc., Actavis LLC, Watson Laboratories Inc..(Gattuso, Dominick) (Entered: 10/31/2014)
|
|
Request |
 |
|
|
32 |
Filed: 10/30/2014, Entered: None |
|
|
NOTICE OF SERVICE of Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.'s Core Technical Documents filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 10/30/2014)
|
|
Request |
 |
|
|
31 |
Filed: 10/30/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.'s Responses to Plaintiff's First Set of Requests for Production (Nos. 1-13); and (2) Aurobindo Pharma Ltd. and Aurobindo Pharma U.S.A., Inc.'s Responses to Plaintiff's First Set of Interrogatories (Nos. 1-7) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth) (Entered: 10/30/2014)
|
|
Request |
 |
|
|
30 |
Filed: 10/23/2014, Entered: None |
|
|
Joint STIPULATION TO EXTEND TIME The Parties to Serve Disclosures Pursuant to District of Delaware Default Standard for Discovery, Paragraph 3 Disclosures to Wednesday, November 19, 2014 (from Friday, November 7, 2014) - filed by AstraZeneca AB. (Silver, Daniel) (Entered: 10/23/2014)
|
|
Request |
 |
|
|
29 |
Filed: 10/23/2014, Entered: None |
|
|
ANSWER to Complaint AstraZeneca AB's Reply to Glenmark's Counterclaims (re D.I. 13 in C.A. No. 14-665-GMS) by AstraZeneca AB.(Silver, Daniel) (Entered: 10/23/2014)
|
|
Request |
 |
|
|
28 |
Filed: 10/22/2014, Entered: None |
|
|
NOTICE of Service of Defendants' First Set of Joint Interrogatories (Nos. 1-7) and Defendants' First Set of Joint Requests for Production of Documents and Things (Nos. 1-97) by Actavis Inc., Actavis LLC, Watson Laboratories Inc. (Gattuso, Dominick) (Entered: 10/22/2014)
|
|
Request |
 |
|
|
27 |
Filed: 10/21/2014, Entered: None |
 |
|
ORDER: On or before Monday, November 10, 2014, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator, Cathleen Kennedy, the information requested in the Order. Signed by Judge Mary Pat Thynge on 10/21/14. (cak) (cak). (Entered: 10/21/2014)
|
|
Request |
 |
|
|
26 |
Filed: 10/17/2014, Entered: None |
|
|
Joint PROPOSED ORDER [Proposed] Scheduling Order as submitted by Plaintiffs and all Defendants by AstraZeneca AB. (Silver, Daniel) (Entered: 10/17/2014)
|
|
Request |
 |
|
|
25 |
Filed: 10/17/2014, Entered: None |
|
|
NOTICE OF SUBSTITUTION OF COUNSEL re Wockhardt Bio AG, Wockhardt USA LLC: Entry of appearance of attorney Richard William Riley. Attorney Gary W. Lipkin terminated. (Riley, Richard) (Entered: 10/17/2014)
|
|
Request |
 |
|
|
24 |
Filed: 10/16/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Joel M. Wallace - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 10/16/2014)
|
|
Request |
 |
|
|
23 |
Filed: 10/15/2014, Entered: None |
 |
|
Official Transcript of Conference held on 10 08 15 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 11/5/2014. Redacted Transcript Deadline set for 11/17/2014. Release of Transcript Restriction set for 1/13/2015. (kjm) (Entered: 10/15/2014)
|
|
Request |
 |
|
|
22 |
Filed: 10/14/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) AstraZeneca AB's Second Set of Requests to Defendants for the Production of Documents and Things and (2) AstraZeneca AB's Second Set of Interrogatories to Defendants filed by AstraZeneca AB.(Silver, Daniel) (Entered: 10/14/2014)
|
|
Request |
 |
|
|
21 |
Filed: 10/9/2014, Entered: None |
|
|
NOTICE OF SERVICE of AstraZeneca AB's Disclosure to Paragraph 4(a) of the Default Standard for Discovery filed by AstraZeneca AB.(Silver, Daniel) (Entered: 10/09/2014)
|
|
Request |
 |
|
|
20 |
Filed: 10/1/2014, Entered: None |
|
|
PROPOSED ORDER Scheduling by AstraZeneca AB. (Silver, Daniel) (Entered: 10/01/2014)
|
|
Request |
 |
|
|
19 |
Filed: 10/1/2014, Entered: None |
|
|
Joint STATUS REPORT by AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Silver, Daniel) (Entered: 10/01/2014)
|
|
Request |
 |
|
|
18 |
Filed: 9/30/2014, Entered: None |
|
|
NOTICE OF SERVICE of (1) Plaintiff's First Set of Requests to Aurobindo for the Production of Documents and Things (Nos. 1-13) and (2) Plaintiff's First Set of Interrogatories to Aurobindo (Nos. 1-7) filed by AstraZeneca AB.(Silver, Daniel) (Entered: 09/30/2014)
|
|
Request |
 |
|
|
17 |
Filed: 9/23/2014, Entered: None |
|
|
Amended Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: No Earlier than April 18, 2014. Date of Expiration of Patent: 7,951,400 (November 30, 2028).Thirty Month Stay Deadline: 1/31/2017. (Silver, Daniel) (Entered: 09/23/2014)
|
|
Request |
 |
|
|
16 |
Filed: 8/13/2014, Entered: None |
|
|
NOTICE of Voluntary Dismissal by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. as to AstraZeneca Pharmaceuticals LP (Dorsney, Kenneth) (Entered: 08/13/2014)
|
|
Request |
 |
|
|
15 |
Filed: 8/8/2014, Entered: None |
|
|
ANSWER to 12 Answer to Complaint, Counterclaim by AstraZeneca AB.(Silver, Daniel) (Entered: 08/08/2014)
|
|
Request |
 |
|
|
14 |
Filed: 7/18/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Gina M. Bassi and Attorney Sailesh K. Patel - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 07/18/2014)
|
|
Request |
 |
|
|
13 |
Filed: 7/18/2014, Entered: None |
|
|
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Ltd. for Aurobindo Pharma USA Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth) (Entered: 07/18/2014)
|
|
Request |
 |
|
|
12 |
Filed: 7/18/2014, Entered: None |
|
|
ANSWER to 1 Complaint, , COUNTERCLAIM against AstraZeneca AB by Aurobindo Pharma USA Inc., Aurobindo Pharma Ltd..(Dorsney, Kenneth) (Entered: 07/18/2014)
|
|
Request |
 |
|
|
11 |
Filed: 7/14/2014, Entered: None |
|
|
MOTION for Pro Hac Vice Appearance of Attorney Charles E. Lipsey, James B. Monroe, Robert F. Shaffer and Maximilienne Bishop - filed by AstraZeneca AB, AstraZeneca AB. (Attachments: # 1 Certification of Charles E. Lipsey, # 2 Certification of James B. Monroe, # 3 Certification of Robert F. Shaffer, # 4 Certification of Maximilienne Bishop)(Silver, Daniel) (Entered: 07/14/2014)
|
|
Request |
 |
|
|
10 |
Filed: 6/19/2014, Entered: None |
 |
|
SO ORDERED - re 9 Stipulation filed by AstraZeneca AB, Set/Reset Answer Deadlines: Aurobindo Pharma Ltd. answer due 7/18/2014; Aurobindo Pharma USA Inc. answer due 7/18/2014. Signed by Chief Judge Gregory M. Sleet on 6/18/2014. (mdb) (Entered: 06/19/2014)
|
|
Request |
 |
|
|
9 |
Filed: 6/17/2014, Entered: None |
|
|
STIPULATION and [Proposed] Order Regarding Defendants' Deadline to Respond to the Complaint is Extended to July 18, 2014 (from June 18, 2014) by AstraZeneca AB. (Silver, Daniel) (Entered: 06/17/2014)
|
|
Request |
 |
|
|
8 |
Filed: 6/10/2014, Entered: None |
|
|
Return of Service Executed by AstraZeneca AB. Aurobindo Pharma USA Inc. served on 5/28/2014, answer due 6/18/2014. (Silver, Daniel) (Entered: 06/10/2014)
|
|
Request |
 |
|
|
7 |
Filed: 6/10/2014, Entered: None |
|
|
DECLARATION of Mailing Regarding Service on Aurobindo Pharma Ltd. made on May 29, 2014 by AstraZeneca AB. (Attachments: # 1 Exhibit A & B)(Silver, Daniel) (Entered: 06/10/2014)
|
|
Request |
 |
|
|
6 |
Filed: 6/10/2014, Entered: None |
|
|
Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (Kelly, Michael) (Entered: 06/10/2014)
|
|
Request |
 |
|
|
5 |
Filed: 5/23/2014, Entered: None |
|
|
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC, Corporate Parent Zeneca Wilmington Inc. for AstraZeneca AB filed by AstraZeneca AB. (cla, ) (Entered: 05/27/2014)
|
|
Request |
 |
|
|
4 |
Filed: 5/23/2014, Entered: None |
|
|
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,951,400;. (cla, ) (Entered: 05/27/2014)
|
|
Request |
 |
|
|
3 |
Filed: 5/23/2014, Entered: None |
|
|
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/18/14. Date of Expiration of Patent: 11/30/28.Thirty Month Stay Deadline: 10/19/2016. (cla, ) (Entered: 05/27/2014)
|
|
Request |
 |
|
|
2 |
Filed: 5/23/2014, Entered: None |
 |
|
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cla, ) (Entered: 05/27/2014)
|
|
Request |
 |
|
|
1 |
Filed: 5/23/2014, Entered: None |
|
|
COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1521343.) - filed by AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(cla, ) (Entered: 05/27/2014)
|
|
|
 |